Page last updated: 2024-12-06

2-methyl-2-oxazoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-methyl-2-oxazoline: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-methyl-2-oxazoline : A 5-membered heterocyclic compound, which is substituted in the 2-position with a methyl group and which is often used as a monomer in polymerisation reactions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID70713
CHEBI ID53614
MeSH IDM0561605

Synonyms (32)

Synonym
26375-28-0
1120-64-5
nsc-43141
nsc43141
oxazole, 4,5-dihydro-2-methyl-
2-methyloxazoline
inchi=1/c4h7no/c1-4-5-2-3-6-4/h2-3h2,1h
2-methyl-2-oxazoline, 98%
2-methyl-2-oxazoline
2-methyl-4,5-dihydro-1,3-oxazole
CHEBI:53614
2-methyl-2-oxazolin
M0857
2-methyl-4,5-dihydrooxazole
methyl oxazoline
2-methyl-oxazoline
nsc 43141
einecs 214-316-3
FT-0612924
2-methyl-1,3-oxazoline
AKOS015915305
2-methyl-4,5-dihydro-1,3-oxazole #
2-oxazoline, 2-methyl-
mfcd00005298
2-methyl-4,5-dihydro-oxazole
4,5-dihydro-2-methyl-1,3-oxazole
F16112
Q27124115
CS-0128804
DTXSID40870845
EN300-172226
oxazole, 4,5-dihydro-2-methyl-, homopolymer
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
oxazoline
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (75.00)24.3611
2020's3 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.51 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index43.41 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]